The CDPath prognostic tool gives Crohn's patients risk scores for serious complications within three years, so they can make more informed treatment decisions.
Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test
Under the agreement, Eagle Biosciences will distribute Genetic Analysis' GA-map Dysbiosis fecal gut microbiota test in North America.
DiaSorin to Acquire Luminex for $1.8B
DiaSorin said that the transaction is expected to be immediately accretive to its earnings per share and result in cost synergies of about $55 million within three years.
DARPA program managers said they are developing different testing modalities that are crucially linked in their objective to facilitate more comprehensive and faster testing.
Appendiceal Cancer Sequences Suggest Distinct Mutation Patterns in Early-, Late-Onset Cases
With clinical sequencing data for almost 400 appendiceal cancer cases, researchers identified somatic differences in individuals diagnosed with the disease before the age of 50.